2022
LGBQ-Affirmative Cognitive-Behavioral Therapy for Young Gay and Bisexual Men’s Mental and Sexual Health: A Three-Arm Randomized Controlled Trial
Pachankis JE, Harkness A, Maciejewski KR, Behari K, Clark KA, McConocha E, Winston R, Adeyinka O, Reynolds J, Bränström R, Esserman DA, Hatzenbuehler ML, Safren SA. LGBQ-Affirmative Cognitive-Behavioral Therapy for Young Gay and Bisexual Men’s Mental and Sexual Health: A Three-Arm Randomized Controlled Trial. Journal Of Consulting And Clinical Psychology 2022, 90: 459-477. PMID: 35482652, PMCID: PMC9446477, DOI: 10.1037/ccp0000724.Peer-Reviewed Original ResearchConceptsHIV transmission risk behaviorsTransmission risk behaviorsHIV testingCognitive behavioral therapyRisk behaviorsSexual healthTransdiagnostic cognitive-behavioral therapyEffect sizeYoung sexual minority menSecondary outcomesPrimary outcomeControl conditionThree-armLarge effect sizesSexual minority menModerate benefitFirst interventionNonsignificant differenceStatistical significanceYoung gayCounselingMonthsGreater reductionTherapyOutcomes
2020
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production
Herold KC, Reynolds J, Dziura J, Baidal D, Gaglia J, Gitelman SE, Gottlieb PA, Marks J, Philipson LH, Pop‐Busui R, Weinstock RS. Exenatide extended release in patients with type 1 diabetes with and without residual insulin production. Diabetes Obesity And Metabolism 2020, 22: 2045-2054. PMID: 32573927, PMCID: PMC8009602, DOI: 10.1111/dom.14121.Peer-Reviewed Original ResearchConceptsExenatide extended releaseResidual insulin productionBeta-cell functionType 1 diabetesC-peptidePlacebo groupPrimary outcomeWeek 12ER groupInsulin productionDetectable C-peptide levelsResidual beta-cell functionGLP-1 receptor agonistsRandomized placebo-controlled trialExtended releaseTotal insulin doseMean HbA1c levelPlacebo-controlled trialC-peptide levelsDetectable levelsCell functionShort-term improvementHbA1c levelsStudy drugAdverse events
2019
Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men’s mental and sexual health
Pachankis JE, McConocha EM, Reynolds JS, Winston R, Adeyinka O, Harkness A, Burton CL, Behari K, Sullivan TJ, Eldahan AI, Esserman DA, Hatzenbuehler ML, Safren SA. Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men’s mental and sexual health. BMC Public Health 2019, 19: 1086. PMID: 31399071, PMCID: PMC6688287, DOI: 10.1186/s12889-019-7346-4.Peer-Reviewed Original ResearchConceptsCo-occurring health risksYoung gayHIV riskSubstance useHealth disparitiesCommunity mental health treatmentMental healthAbsence of PrEPUndetectable viral loadHigh-risk groupSexual health problemsCondomless anal sexSkills-building interventionMental health treatmentAdult Sexual Minority MenSubstance use problemsBisexual men’s healthSecondary outcomesHIV counselingHIV infectionPrEP uptakePrimary outcomeViral loadEvidence-based practicePsychiatric morbidity